Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

被引：14
|
作者：
Nishimura, T
Watanabe, K
Lee, U
Yahata, T
Ando, K
Kimura, M
Hiroyama, Y
Kobayashi, M
Herrmann, SH
Habu, S
机构：
[1] TOKAI UNIV,SCH MED,DEPT INFECT DIS,ISEHARA,KANAGAWA 25911,JAPAN
[2] TOKAI UNIV,SCH MED,DEPT MOLEC LIFE SCI,ISEHARA,KANAGAWA 25911,JAPAN
[3] DNARD INC,KAWASAKI,KANAGAWA 216,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
来源：
IMMUNOLOGY LETTERS | 1995年 / 48卷 / 02期
关键词：
interleukin-12; tumor immunotherapy; primary tumor; mouse;
D O I：
10.1016/0165-2478(95)02448-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：149 / 152
页数：4
相关论文
共 50 条
  • [31] Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity
    Yang, Lirong
    Zaharoff, David A.
    BIOMATERIALS, 2013, 34 (15) : 3828 - 3836
  • [32] INHIBITION OF ANGIOGENESIS IN-VIVO BY INTERLEUKIN-12
    VOEST, EE
    KENYON, BB
    OREILLY, MS
    TRUITT, G
    DAMATO, RJ
    FOLKMAN, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (08) : 581 - 586
  • [33] Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer
    Sean G. Smith
    Bhanu prasanth Koppolu
    Sruthi Ravindranathan
    Samantha L. Kurtz
    Lirong Yang
    Matthew D. Katz
    David A. Zaharoff
    Cancer Immunology, Immunotherapy, 2015, 64 : 689 - 696
  • [34] Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer
    Smith, Sean G.
    Koppolu, Bhanu Prasanth
    Ravindranathan, Sruthi
    Kurtz, Samantha L.
    Yang, Lirong
    Katz, Matthew D.
    Zaharoff, David A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (06) : 689 - 696
  • [35] ANTITUMOR EFFECTS OF INTERLEUKIN-12 GENE THERAPY COMBINED WITH CHEMOTHERAPY AGAINST BLADDER CANCER IN VITRO
    Cao, Yanwei
    Liu, Wanpeng
    Xiu, Youcheng
    Shao, Shixiu
    Fernandez, Mario I.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 348 - 348
  • [36] THE IN-VIVO ANTIVIRAL ACTIVITY OF INTERLEUKIN-12 IS MEDIATED BY GAMMA-INTERFERON
    OZMEN, L
    AGUET, M
    TRINCHIERI, G
    GAROTTA, G
    JOURNAL OF VIROLOGY, 1995, 69 (12) : 8147 - 8150
  • [37] ADDITION OF INTERLEUKIN-12 TO LOW-DOSE INTERLEUKIN-2 TREATMENT IMPROVES ANTITUMOR EFFICACY IN-VIVO
    LEDER, GH
    OPPENHEIM, M
    ROSENSTEIN, M
    LOTZE, MT
    BERGER, HG
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1995, 33 (09): : 499 - 502
  • [38] INTRAVESICAL IMMUNOTHERAPY WITH CHITOSAN AND INTERLEUKIN-12 INDUCES SYSTEMIC TUMOR-SPECIFIC IMMUNITY
    Smith, Sean
    Yang, Lirong
    Vo, Jimmy
    Zaharoff, David
    JOURNAL OF UROLOGY, 2013, 189 (04): : E238 - E239
  • [39] Interleukin-12 enhances the antitumor activity of cytotoxic T lymphocytes against lung adenocarcinoma engrafted in severe combined immunodeficient mice
    Hanagiri T.
    Imahayashi S.
    Yoshino I.
    So T.
    Eifuku R.
    Yoshimatsu T.
    Takenoyama M.
    Osaki T.
    Nakanishi R.
    Ichiyoshi Y.
    Nomoto K.
    Yasumoto K.
    International Journal of Clinical Oncology, 2000, 5 (4) : 262 - 268
  • [40] Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12
    Hernandez-Alcoceba, Ruben
    Poutou, Joanna
    Cristina Ballesteros-Briones, Maria
    Smerdou, Cristian
    IMMUNOTHERAPY, 2016, 8 (02) : 179 - 198
12345